Alcohol-induced generation of lipid peroxidation products in humans

Journal of Clinical Investigation

Volumn 104, Issue 6, 1999, Pages 805-813

  Meagher, Emma A ^a   Barry, Orla P ^a   Burke, Anne ^a   Lucey, Michael R ^a   Lawson, John A ^a   Rokach, Joshua ^b   FitzGerald, Garret A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FLORIDA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ASCORBIC ACID; LIPID PEROXIDE; PLACEBO;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

EID: 0032741862     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5584     Document Type: Article

References (60)

1. Doll, R., Peto, R., Hall, E., Wheatley, K., and Gray, R. 1994. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. Br. Med. J. 309:911-918.
2. Fuchs, C.S., et al. 1995. Alcohol consumption and mortality among women. N. Eng. J. Mid. 332:1245-1250.
3. Garfinkel, L., Boffetta, P., and Stellman, S.D. 1988. Alcohol and breast cancer: a cohort study. Prev. Med. 17:686-693.
4. Decker, U., et al. 1996. Prediction of risk of liver disease by alcohol intake, sex and age: a prospective study. Hepatology. 23:1025-1029.
5. Bellentani, S., et al. 1997. Drinking habits as a cofactor of risk for alcohol induced liver damage. Gut. 41:845-850.
6. Friedman, S.L. 1993. Seminars in medicine of the Beth Israel Hospital, Boston, The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med. 328:1828-1835.
7. Britton, R.S., and Bacon, B.R. 1994. Role of free radicals in liver diseases and hepatic fibrosis. Hepato-Gastroenterology. 41:343-348.
8. Lieber, C.S., and DeCarli, L.M. 1970. Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo. J. Biol. Chem. 245:2505-2512.
9. Tsukamoto, H. 1993. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol. 10:465-467.
10. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F.P. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:414-423.
11. Nanji, A.A., and French, S.W. 1989. Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci. 44:223-227.
12. Smith, C.V., and Anderson, R.E. 1987. Merhods for determination of lipid peroxidation in biological samples. Free Radic. Biol. Med. 3:341-344.
13. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA. 87:9383-9387.
14. 2-isoprostane) metabolites in human urine and plasma. J. Biol. Chem. 268:4161-4169.
15. Patrono, C., and FitzGerald, G.A. 1997. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease [review]. Arterioscler. Thromb. Vasc. Biol. 7:2309-2315.
16. Lawson, J.A., Rokach, J., and FitzGerald, G.A. 1999. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo [review]. J. Biol. Chem. In press.
17. 2α in human platelets. J. Biol. Chem. 270:9800-9808.
18. 2α-I: an index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. USA. 95:3449-3454.
19. Reilly, M., Delanty, N., Lawson, J.A., and FitzGerald, G.A. 1996. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 94:19-25.
20. 2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation. 95:2492-2499.
21. 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation. 96:3314-3320.
22. Praticò, D., Tangirala, R.K., Rader, D.J., Rokach, J., and FitzGerald, G.A. 1998. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat. Med. 4:1189-1192.
23. Esterbauer, H., Schaur, R.J., and Zollner, H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128.
24. Smucker, R., Block, G., Coyle, L., Harvin, A., and Kessler, L. 1989. A dietary and risk factor questionnaire and analysis system for personal computers. Am. J. Epidemiol. 129:445-449.
25. Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C., and Williams, R. 1973. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60:646-649.
26. Beresford, T., Blow, F.C., Hiu, E.M., Singer, K., and Lucey, M.R. 1990. Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism. Lancet. 336:462-485.
27. 2α in humans. J. Biol. Chem. 271:20617-20620.
28. 2α. J. Biol. Chem. 15:1313-1319.
29. Carithers, R.L., Jr., et al. 1989. Methylprednisone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann. Intern. Med. 110:685-690.
30. 2α by human monocytes: discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J. Biol. Chem. 271:8919-8924.
31. 2α and utility for quantitative mass spectrometry. Anal. Biochem. 111:115-121.
32. van Kuijk, F.J., Siakotos, A.N., Fong, L.G., Stephens, R.J., and Thomas, D.W. 1995. Quantitative measurement of 4-hydroxyalkenals in oxidized low-density lipoprotein by gas chromatography-mass spectrometry. Anal. Biochem. 224:420-424.
33. Kaplan, L.A., Miler, J.A., and Stein, E.A. 1987. Simultaneous measurement of serum retinol, tocopherols, carotenes, and carotenoids by high performance liquid chromatography. J. Clin. Lab. Anal. 1:147-152.
34. Baldwin, J.N., and Tong, T.G. 1996. Alcoholism. In Textbook of therapeutics: drug and disease management. 6th edition. E.T. Herfindal and D.R. Gourley, editors. Williams & Wilkins. Baltimore, MD.
35. Corrao, G., and Arico, S. 1998. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology. 27:915-919.
36. Marmot, M.G., Shipley, M.J., Rose, G., and Thomas, B.J. 1981. Alcohol and mortality: a U-shaped curve. Lancet. 1:580-583.
37. Renaud, S., and Orgeril, M. 1992. Wine alcohol, platelets and the French paradox for coronary heart disease. Lancet. 339:1523-1526.
38. Tsukamoto, H., et al. 1995. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 96:620-630.
39. Rouach, H., et al. 1997. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology. 25:351-355.
40. Tsukamoto, H., Towner, S.J., Ciofalo, L.M., and French, S.W. 1986. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology. 6:814-822.
41. 4 in rats and by alcohol in baboons. Gastroenterology. 108(Suppl.):A1025. (Abstr.)
42. Lieber, C.S. 1999. Prevention and treatment of liver fibrosis based on pathogenesis. Alcohol Clin. Exp. Res. 23:944-949.
43. Leo, M.A., Rosman, A.S., and Lieber, C.S. 1993. Differential depletion of carotenoids and tocopherol in liver disease. Hepatology. 17:977-986.
44. Sadrzadeh, S.M., Nanji, A.A., and Meydani, M. 1994. Effect of chronic ethanol feeding on plasma and liver alpha- and gamma-tocopherol levels in normal and vitamin E-deficient rats. Relationship to lipid peroxidation. Biochem. Pharmacol. 47:2005-2010.
45. Frezza, M., et al. 1990. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N. Engl. J. Med. 322:95-99.
46. Loft, S., Olesen, K.L., and Dossing, M. 1987. Increased susceptibility to liver disease in relation to alcohol consumption in women. Scand. J. Gastroenterol. 22:1251-1256.
47. Frankel, E.N., Kanner, J., German, J.B., Parks, E., and Kinsella, J.E. 1993. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:454-457.
48. Rifici, V.A., and Khachadurian, A.K. 1998. Polyphenols found in red wine inhibit cell mediated lipoprotein oxidation. J. Invest. Med. 46(Suppl.):2907A. (Abstr.)
49. Hayek, T., et al. 1997. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17:2744-2752.
50. Rokach, J., et al. 1998. The isoprostanes, a new class of natural products: synthesis and biosynthesis. Synthesis. 1:569-580.
51. 2-isoprostanes formed by free radical oxidation of arachidonic acid. J. Am. Soc. Mass Spectrom. 7:490-499.
52. Nanji, A.A., Khwaja, S., Tahan, S.R., and Sadrzadeh, S.M.H. 1994. Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J. Pharmacol. Exp. Ther. 269:1280-1285.
53. Aleynik, S.I., Leo, M.A., Aleynik, M.K., and Lieber, C.S. 1998. Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol Clin. Exp. Res. 22:192-196.
54. 2 isoprostanes in hypercholesterolemia. Circulation. 98: 2822-2828.
55. 2α is increased in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17:3230-3235.
56. 2 isoptostanes in human atherosclerotic lesions. J. Clin. Invest. 100:2028-2034.
57. Iuliano, L., et al. 1998. Enhanced lipid peroxidation in patients with hepatic cirrhosis. J. Invest. Med. 46:51-57.
58. Pawlosky, R.J., Flynn, B.M., and Salem, N., Jr. 1997. The effects of low dietary levels of polyunsaturates on alcohol-induced liver disease in rhesus monkeys. Hepatology. 26:1386-1392.
59. 2 receptors. J. Clin. Invest. 90:136-141.
60. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 264:C1619-C1624.